Researchers from the Pharmacopeia group found that between 26% and 44% of anti-malaria drugs in Uganda, Senegal and Madagascar were of poor quality.
Cilmi baarayaal ka socday kooxda la yiraahdo Pharmacopeia ayaa shaaciyay in inta u dhaxeysa 26% iyo 44% daawada mallaariyada ee laga isticmaalo dalalka Uganda, Madagascar iyo Senegal ay aad u hooseyso tayadooda.